Nerve Targeting Peptide Conjugates for Surgical Visualization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying and visualizing human nerves during surgical procedures are inadequate, as they lack visual feedback and are not effective in tracing sensory fibers or providing accurate visualization of nerve pathways, especially in complex scenarios like trauma or tumor involvement.

Innovation Solution

Development of nerve-targeting peptide conjugates that selectively bind to human nerves, allowing for the delivery of cargo molecules such as fluorescent moieties or photosensitizing agents, enabling precise visualization and targeting of nerves during surgery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If fluorescent dyes are used for neuron or nerve labeling, then nerve identification is possible, but the surgical site becomes contaminated and visualization is compromised

Engineering Contradiction:
Improvenerve identification accuracyVSAvoidsurgical site contamination
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the harmful fluorescent dye from the injection site and relocates it to a distant target organ through the bloodstream. The dye is injected into a vein, allowing it to be carried by blood flow to the target nerve, thereby separating the contamination source from the surgical site while maintaining nerve labeling capability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces blood as an intermediary medium to transport the fluorescent dye from the injection site to the target nerve. This intermediary carrier allows the dye to reach the nerve without direct contact with the surgical site, eliminating contamination while preserving labeling effectiveness

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If retrograde axonal tracers are used for nerve labeling, then nerve pathways can be traced, but the labeling process is slow and takes a long time

Engineering Contradiction:
Improvenerve pathway tracingVSAvoidlabeling time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent inverts the traditional retrograde tracing approach by using anterograde transport via blood flow. Instead of waiting for slow retrograde axonal transport to carry dye from the nerve ending back to the cell body, the dye is delivered directly to the nerve through the bloodstream, achieving rapid labeling in minutes rather than days

Inventive Principle:
Principle #13The other way round (Inversion)

3Measurement precision

If direct intramuscular injection of fluorescent dye is used for nerve labeling, then nerve targeting is achieved, but mechanical damage and high local concentration of dye occur

Engineering Contradiction:
Improvenerve targeting accuracyVSAvoidmechanical damage and dye concentration toxicity
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the harmful effects of direct injection by routing the dye through the bloodstream instead of direct intramuscular injection. This eliminates mechanical damage from needle insertion and avoids the toxic high local concentration of dye at the injection site, while still achieving precise nerve targeting through blood flow distribution

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The peptide conjugates provide effective visualization and targeting of human nerves, overcoming the limitations of existing methods by offering selective binding and accurate identification of nerve pathways, enhancing surgical precision and safety.

Implementation Method 1

peptide conjugates that selectively bind to human nerves

Methodology Applied
Scientific EffectSelective binding:

Implementation Method 2

cargo molecules such as fluorescent moieties or photosensitizing agents

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS20240207421A1Nerve targeting peptides and methods of use
Publication Date: 2024.06.27 ALUME BIOSCIENCES INC

AI summary

The present disclosure provides nerve targeting peptides, including those comprising the amino acid sequence of any one of SEQ ID NOS: 1-710; conjugates comprising such nerve targeting peptides and a cargo molecule; compositions comprising said peptides and conjugates; and methods of said peptides and conjugates in surgical procedures and other applications.